Product Details
Survanta Intratracheal
Beractant25 mg/mL
Suspension
ROA
Intratracheal
Applicant Name
Phillips Pharmaceuticals (Nigeria) Limited
NRN
B4-9922
Status
Active
Composition
ATC Code
R07AA02
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
Product Description
Intratracheal suspension in single-use glass vial. Each mL contains 25 mg of phospholipids suspended in 0.9% sodium chloride solution
Manufacturer Name
AbbVie Inc.
Manufacturer Country
INDIA
Approval Date
2019-07-30
Expiry Date
2024-07-29